90TEN picked up the Communiqué Communications Consultancy of the Year at last night’s 2019 Communiqué Awards in London, seeing off competition from GCI, Hanover Health, In
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh